Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia

Curr Oncol Rep. 2008 Sep;10(5):363-4. doi: 10.1007/s11912-008-0056-1.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use
  • Disease-Free Survival
  • Flow Cytometry / methods
  • Humans
  • Immunotherapy / methods*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Middle Aged
  • Remission Induction
  • Rituximab
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vidarabine
  • fludarabine